Charles Murry, UW professor of bioengineering, pathology and medicine/cardiology and pioneering cardiac disease researcher, will be honored at the Northwest Association for Biomedical Research (NWABR) Speak up for Research Gala on June 9, 2016.
UW Bioengineering faculty Charles Murry, Michael Regnier, Ruikang Wang and adjunct faculty Tueng Shen were inducted to the AIMBE College of Fellows Class of 2016 at the AIMBE Annual Event, which was held April 3-4 in Washington, D.C.
UW professor of pathology, bioengineering and medicine/cardiology Charles Murry's career led him from medical school to a PhD and back again, to his current work at the forefront of cardiac stem cell science and engineering.
Dr. Charles Murry, UW professor of pathology, cardiology and bioengineering, will present the first lecture in UW’s 2014 Engineering Lecture Series, “Engineering the Heart: From Cell Therapy to Computer Technology”. Dr. Murry will present a talk entitled “Engineering a Broken Heart”, on October 15, 2014.
UW Bioengineering faculty Charles Murry (joint professor of pathology, bioengineering and medicine/cardiology) and Michael Regnier, as well as adjunct faculty Michael Jensen, MD, director of the Ben Towne Center for Childhood Cancer at Seattle Children’s Research Institute and professor of pediatric hematology-oncology at UW Medicine and Satoshi Minoshima, professor of radiology, were named 2014 UW Presidential Entrepreneurial Faculty Fellows.
The Seattle Times reports that Dr. Charles Murry, UW professor of pathology, bioengineering and cardiology, and colleagues have successfully regenerated heart muscle in monkeys using human stem cells. This "proof-of-concept" research may one day be applied to humans whose hearts are damaged by heart attack and shows promising progress towards solving the "burgeoning public-health problem" of cardiac disease.
Stem cell therapy regenerates heart muscle in primates, finds a study led by Dr. Charles Murry, UW professor of pathology, bioengineering and cardiology. This approach, which uses heart cells created from human embryonic stem cells, should be feasible in humans and may be ready for clinical trials in humans within four years, researchers say. The study was published in the advanced online April 30, 2014 edition of Nature.
The heart cannot heal itself very well. However, Dr. Charles Murry, professor of Pathology, Bioengineering and Cardiology, is working on new ways to repair heart damage.
UW Bioengineering professor Dr. Charles Murry (joint in Cardiology and Pathology) and adjunct faculty Dr. François Baneyx (professor of Chemical Engineering) are among 5 UW faculty members recently named American Association for the Advancement of Science (AAAS) Fellows.